{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:51:13Z","timestamp":1792165873808,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T00:00:00Z","timestamp":1626912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009433","name":"Istituto Auxologico Italiano","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009433","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.eprac.2021.07.014","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T08:46:48Z","timestamp":1627375608000},"page":"1216-1224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["When to Suspect Hidden Hypercortisolism in Type 2 Diabetes: A Meta-Analysis"],"prefix":"10.1016","volume":"27","author":[{"given":"Carmen","family":"Aresta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Soranna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Giovanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Favero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Parazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Gennari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Persani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Scillitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis S.","family":"Blevins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Einhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Pantalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Otto","family":"Lunde J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Zambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7594-3300","authenticated-orcid":false,"given":"Iacopo","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.eprac.2021.07.014_bib1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing\u2019s syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"10.1016\/j.eprac.2021.07.014_bib2","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/jc.2010-2722","article-title":"Clinical review: diagnosis and treatment of subclinical hypercortisolism","volume":"96","author":"Chiodini","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2021.07.014_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ando.2018.03.005","article-title":"Cardiovascular mortality in patients with subclinical Cushing","volume":"79","author":"Morelli","year":"2018","journal-title":"Ann Endocrinol (Paris)"},{"issue":"8","key":"10.1016\/j.eprac.2021.07.014_bib4","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s40618-020-01484-2","article-title":"Hidden hypercortisolism: a too frequently neglected clinical condition","volume":"44","author":"Giovanelli","year":"2021","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"8","key":"10.1016\/j.eprac.2021.07.014_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-147-8-200710160-00006","article-title":"Subclinical hypercortisolism among outpatients referred for osteoporosis","volume":"147","author":"Chiodini","year":"2007","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.eprac.2021.07.014_bib6","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1530\/EJE-16-0289","article-title":"Mechanisms in endocrinology: endogenous subclinical hypercortisolism and bone: a clinical review","volume":"175","author":"Chiodini","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2021.07.014_bib7","doi-asserted-by":"crossref","first-page":"R247","DOI":"10.1530\/EJE-16-0434","article-title":"Diagnosis of endocrine disease: prevalence of hypercortisolism in type 2 diabetes patients: a systematic review and meta-analysis","volume":"175","author":"Steffensen","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2021.07.014_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/EJE-15-0977","article-title":"Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism","volume":"174","author":"Salcuni","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2021.07.014_bib9","doi-asserted-by":"crossref","first-page":"R283","DOI":"10.1530\/EJE-16-0465","article-title":"Therapy of endocrine disease: improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing\u2019s syndrome: a systematic review and meta-analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2021.07.014_bib10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1530\/EJE-12-0803","article-title":"The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism","volume":"168","author":"Palmieri","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.eprac.2021.07.014_bib11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ecl.2018.01.003","article-title":"Recent advances on subclinical hypercortisolism","volume":"47","author":"Zavatta","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"10.1016\/j.eprac.2021.07.014_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ando.2018.03.013","article-title":"Do the diagnostic criteria for subclinical hypercortisolism exist?","volume":"79","author":"Tabarin","year":"2018","journal-title":"Ann Endocrinol (Paris)"},{"issue":"2","key":"10.1016\/j.eprac.2021.07.014_bib13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12020-016-1017-3","article-title":"Six controversial issues on subclinical Cushing\u2019s syndrome","volume":"56","author":"Chiodini","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.eprac.2021.07.014_bib14","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3389\/fendo.2019.00766","article-title":"Toward a diagnostic score in Cushing\u2019s syndrome","volume":"10","author":"Braun","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.eprac.2021.07.014_bib15","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-18-0991","article-title":"Diagnosis of endocrine disease: evaluation of bone fragility in endocrine disorders","author":"Eller-Vainicher","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.eprac.2021.07.014_bib16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2265.1996.737558.x","article-title":"Pre-clinical Cushing\u2019s syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients","volume":"44","author":"Leibowitz","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.eprac.2021.07.014_bib17","first-page":"326","article-title":"Deteccion de sindrome de cushing preclinico en pacientes con sobrepeso y diabetes mellitus tipo 2","volume":"60","author":"Contreras","year":"2000","journal-title":"Medicina"},{"issue":"4","key":"10.1016\/j.eprac.2021.07.014_bib18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1530\/EC-15-0078","article-title":"Is it worthwhile to screen patients with type 2 diabetes mellitus for subclinical Cushing\u2019s syndrome?","volume":"4","author":"Budyal","year":"2015","journal-title":"Endocr Connect"},{"issue":"6","key":"10.1016\/j.eprac.2021.07.014_bib19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2265.2005.02395.x","article-title":"Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans","volume":"63","author":"Liu","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.eprac.2021.07.014_bib20","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1210\/jc.2003-030254","article-title":"Occult Cushing\u2019s syndrome in type-2 diabetes","volume":"88","author":"Catargi","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2021.07.014_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2265.2007.02865.x","article-title":"Screening of Cushing\u2019s syndrome in adult patients with newly diagnosed diabetes mellitus","volume":"67","author":"Reimondo","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.eprac.2021.07.014_bib22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1445-5994.2007.01434.x","article-title":"Cushing\u2019s syndrome in a clinic population with diabetes","volume":"38","author":"Newsome","year":"2008","journal-title":"Intern Med J"},{"issue":"2","key":"10.1016\/j.eprac.2021.07.014_bib23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1507\/endocrj.K07E-045","article-title":"Subclinical hypercortisolism in hospitalized patients with type 2 diabetes mellitus","volume":"55","author":"Taniguchi","year":"2008","journal-title":"Endocr J"},{"issue":"3","key":"10.1016\/j.eprac.2021.07.014_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1507\/endocrj.K09E-352","article-title":"The frequency of type 2 diabetic patients who meet the endocrinological screening criteria of subclinical Cushing\u2019s disease","volume":"57","author":"Murakami","year":"2010","journal-title":"Endocr J"},{"issue":"5","key":"10.1016\/j.eprac.2021.07.014_bib25","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1210\/jc.2009-2453","article-title":"Is there value in routine screening for Cushing\u2019s syndrome in patients with diabetes?","volume":"95","author":"Mullan","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2021.07.014_bib26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1055\/s-0029-1246191","article-title":"Screening for subclinical Cushing\u2019s syndrome in type 2 diabetes mellitus: low false-positive rates with nocturnal salivary cortisol","volume":"42","author":"Gagliardi","year":"2010","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.1016\/j.eprac.2021.07.014_bib27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13410-012-0091-1","article-title":"Screening for Cushing\u2019s syndrome in obese type 2 diabetic patients and the predictive factors on the degree of serum cortisol suppression","volume":"32","author":"Mert","year":"2012","journal-title":"Int J Diabetes Dev Ctries"},{"issue":"6","key":"10.1016\/j.eprac.2021.07.014_bib28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1530\/eje.1.02045","article-title":"Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients","volume":"153","author":"Chiodini","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2021.07.014_bib29","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1590\/S0004-27302007000700015","article-title":"Increased diagnostic probability of subclinical Cushing\u2019s syndrome in a population sample of overweight adult patients with type 2 diabetes mellitus","volume":"51","author":"Caetano","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"10","key":"10.1016\/j.eprac.2021.07.014_bib30","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1210\/jc.2012-1323","article-title":"Screening of Cushing\u2019s syndrome in outpatients with type 2 diabetes: results of a prospective multicentric study in Italy","volume":"97","author":"Terzolo","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2021.07.014_bib31","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jdiacomp.2016.05.006","article-title":"Prevalence of subclinical hypercortisolism in type 2 diabetic patients from the Rio de Janeiro Type 2 Diabetes Cohort Study","volume":"30","author":"Costa","year":"2016","journal-title":"J\u00a0Diabetes Complications"},{"issue":"1","key":"10.1016\/j.eprac.2021.07.014_bib32","first-page":"22","article-title":"Which type 2 diabetes mellitus patients should be screened for subclinical Cushing\u2019s syndrome?","volume":"16","author":"Cansu","year":"2017","journal-title":"Hormones (Athens)"},{"issue":"1","key":"10.1016\/j.eprac.2021.07.014_bib33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/a-0809-3647","article-title":"Hypercortisolism in newly diagnosed type 2 diabetes: a prospective study of 384 newly diagnosed patients","volume":"51","author":"Steffensen","year":"2019","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.eprac.2021.07.014_bib34","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.eprac.2021.07.014_bib35","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 16: Special topics in statistics","author":"Higgins","year":"2011"},{"key":"10.1016\/j.eprac.2021.07.014_bib36","author":"Wells"},{"key":"10.1016\/j.eprac.2021.07.014_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12874-015-0091-1","article-title":"Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies","volume":"15","author":"R\u00f6ver","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.eprac.2021.07.014_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Methodol"},{"issue":"25","key":"10.1016\/j.eprac.2021.07.014_bib39","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1002\/sim.7411","article-title":"The Hartung-Knapp modification for random-effects meta-analysis: a useful refinement but are there any residual concerns?","volume":"36","author":"Jackson","year":"2017","journal-title":"Stat Med"},{"issue":"5","key":"10.1016\/j.eprac.2021.07.014_bib40","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1037\/h0031619","article-title":"Measuring nominal scale agreement among many raters","volume":"76","author":"Fleiss","year":"1971","journal-title":"Psychol Bull"},{"issue":"10","key":"10.1016\/j.eprac.2021.07.014_bib41","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1210\/jc.2016-1673","article-title":"A\u00a0probabilistic model for Cushing\u2019s syndrome screening in at-risk populations: a prospective multicenter study","volume":"101","author":"Le\u00f3n-Justel","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.eprac.2021.07.014_bib42","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/jamasurg.2020.3280","article-title":"Evaluation and treatment of patients with hypercortisolism: a review","volume":"155","author":"Miller","year":"2020","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.eprac.2021.07.014_bib43","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s12020-021-02645-w","article-title":"Update on primary bilateral macronodular adrenal hyperplasia (PBMAH)","volume":"71","author":"Bouys","year":"2021","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.eprac.2021.07.014_bib44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"12","key":"10.1016\/j.eprac.2021.07.014_bib45","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/jc.2014-3007","article-title":"Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas","volume":"99","author":"Debono","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2021.07.014_bib46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","article-title":"Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center","volume":"58","author":"Patrova","year":"2017","journal-title":"Endocrine"},{"issue":"suppl 3","key":"10.1016\/j.eprac.2021.07.014_bib47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S1530-891X(20)44298-3","article-title":"Screening of diabetic patients using U500 insulin uncovers a high percentage of undiagnosed hypercortisolism consistent with Cushing\u2019s syndrome","volume":"23","author":"Mathews","year":"2017","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.eprac.2021.07.014_bib48","doi-asserted-by":"crossref","first-page":"101519","DOI":"10.1016\/j.beem.2021.101519","article-title":"Biochemical diagnosis of Cushing\u2019s disease: screening and confirmatory testing","volume":"35","author":"Petersenn","year":"2021","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2021.07.014_bib49","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.metabol.2006.04.010","article-title":"Hypothalamic-pituitary-adrenal activity in type 2 diabetes mellitus: role of autonomic imbalance","volume":"55","author":"Chiodini","year":"2006","journal-title":"Metabolism"}],"updated-by":[{"DOI":"10.1016\/j.eprac.2022.03.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000}}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21011484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X21011484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T16:25:54Z","timestamp":1668788754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X21011484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1530891X21011484"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2021.07.014","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.eprac.2022.03.008","asserted-by":"object"}]},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When to Suspect Hidden Hypercortisolism in Type 2 Diabetes: A Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2021.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}